skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: EBSCOhost Academic Search Premier remover idioma: Russo remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

Bissler, John J, Prof ; Kingswood, J Christopher, FRCP ; Radzikowska, Elżbieta, MD ; Zonnenberg, Bernard A, MD ; Frost, Michael, MD ; Belousova, Elena, Prof ; Sauter, Matthias, MD ; Nonomura, Norio, Prof ; Brakemeier, Susanne, MD ; de Vries, Petrus J, Prof ; Whittemore, Vicky H, PhD ; Chen, David, PhD ; Sahmoud, Tarek, MD ; Shah, Gaurav, MD ; Lincy, Jeremie, MS ; Lebwohl, David, MD ; Budde, Klemens, Prof

The Lancet (British edition), 2013-03, Vol.381 (9869), p.817-824 [Periódico revisado por pares]

Kidlington: Elsevier

Texto completo disponível

Citações Citado por
2
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Fuchs, Charles S, Dr Prof ; Tomasek, Jiri, MD ; Yong, Cho Jae, Prof ; Dumitru, Filip, MD ; Passalacqua, Rodolfo, MD ; Goswami, Chanchal, Prof ; Safran, Howard, Prof ; dos Santos, Lucas Vieira, MD ; Aprile, Giuseppe, MD ; Ferry, David R, Prof ; Melichar, Bohuslav, Prof ; Tehfe, Mustapha, MD ; Topuzov, Eldar, Prof ; Zalcberg, John Raymond, Prof ; Chau, Ian, MD ; Campbell, William, Prof ; Sivanandan, Choondal, MD ; Pikiel, Joanna, MD ; Koshiji, Minori, MD ; Hsu, Yanzhi, PhD ; Liepa, Astra M, PharmD ; Gao, Ling, PhD ; Schwartz, Jonathan D, MD ; Tabernero, Josep, MD

The Lancet (British edition), 2014-01, Vol.383 (9911), p.31-39 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Social and structural risks for HIV among migrant and immigrant men who have sex with men in Moscow, Russia: Implications for prevention
Social and structural risks for HIV among migrant and immigrant men who have sex with men in Moscow, Russia: Implications for prevention
Material Type:
Artigo 		Adicionar ao Meu Espaço

Social and structural risks for HIV among migrant and immigrant men who have sex with men in Moscow, Russia: Implications for prevention

Wirtz, A.L. ; Zelaya, C.E. ; Peryshkina, A. ; Latkin, C. ; Mogilnyi, V. ; Galai, N. ; Dyakonov, K. ; Beyrer, C.

AIDS care, 2014-03, Vol.26 (3), p.387-395 [Periódico revisado por pares]

Abingdon: Taylor & Francis

Texto completo disponível

Citações Citado por
4
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

Jacobson, Ira M, Prof ; Dore, Gregory J, Prof ; Foster, Graham R, Prof ; Fried, Michael W, Prof ; Radu, Monica, MD ; Rafalsky, Vladimir V, Prof ; Moroz, Larysa, Prof ; Craxi, Antonio, Prof ; Peeters, Monika, MSc ; Lenz, Oliver, PhD ; Ouwerkerk-Mahadevan, Sivi, PhD ; De La Rosa, Guy, MD ; Kalmeijer, Ronald, MD ; Scott, Jane, PhD ; Sinha, Rekha, PhD ; Beumont-Mauviel, Maria, PhD

The Lancet (British edition), 2014-08, Vol.384 (9941), p.403-413 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

Franz, David Neal, Prof ; Belousova, Elena, MD ; Sparagana, Steven, MD ; Bebin, E Martina, MD ; Frost, Michael, MD ; Kuperman, Rachel, MD ; Witt, Olaf, MD ; Kohrman, Michael H, MD ; Flamini, J Robert, MD ; Wu, Joyce Y, MD ; Curatolo, Paolo, Prof ; de Vries, Petrus J, Prof ; Whittemore, Vicky H, PhD ; Thiele, Elizabeth A, MD ; Ford, James P, MS ; Shah, Gaurav, MD ; Cauwel, Helene, MSc ; Lebwohl, David, MD ; Sahmoud, Tarek, MD ; Jozwiak, Sergiusz, MD

The Lancet (British edition), 2013-01, Vol.381 (9861), p.125-132 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Navarra, Sandra V, MD ; Guzmán, Renato M, MD ; Gallacher, Alberto E, MD ; Hall, Stephen, MD ; Levy, Roger A, MD ; Jimenez, Renato E, MD ; Li, Edmund K-M, MD ; Thomas, Mathew, MD ; Kim, Ho-Youn, MD ; León, Manuel G, MD ; Tanasescu, Coman, MD ; Nasonov, Eugeny, MD ; Lan, Joung-Liang, MD ; Pineda, Lilia, MD ; Zhong, Z John, PhD ; Freimuth, William, MD ; Petri, Michelle A, MD

The Lancet (British edition), 2011, Vol.377 (9767), p.721-731 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Effect of epidural stimulation of the lumbosacral spinal cord on voluntary movement, standing, and assisted stepping after motor complete paraplegia: a case study
Effect of epidural stimulation of the lumbosacral spinal cord on voluntary movement, standing, and assisted stepping after motor complete paraplegia: a case study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of epidural stimulation of the lumbosacral spinal cord on voluntary movement, standing, and assisted stepping after motor complete paraplegia: a case study

Harkema, Susan, Prof ; Gerasimenko, Yury, PhD ; Hodes, Jonathan, MD ; Burdick, Joel, Prof ; Angeli, Claudia, PhD ; Chen, Yangsheng, PhD ; Ferreira, Christie, BSc ; Willhite, Andrea, BA ; Rejc, Enrico, MSc ; Grossman, Robert G, Prof ; Edgerton, V Reggie, Prof

The Lancet (British edition), 2011-06, Vol.377 (9781), p.1938-1947 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
Material Type:
Artigo 		Adicionar ao Meu Espaço

Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007

Skiada, A. ; Pagano, L. ; Groll, A. ; Zimmerli, S. ; Dupont, B. ; Lagrou, K. ; Lass-Florl, C. ; Bouza, E. ; Klimko, N. ; Gaustad, P. ; Richardson, M. ; Hamal, P. ; Akova, M. ; Meis, J.F. ; Rodriguez-Tudela, J.-L. ; Roilides, E. ; Mitrousia-Ziouva, A. ; Petrikkos, G.

Clinical microbiology and infection, 2011-12, Vol.17 (12), p.1859-1867 [Periódico revisado por pares]

Oxford, UK: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Adverse childhood experiences and associations with health-harming behaviours in young adults: surveys in eight eastern European countries
Adverse childhood experiences and associations with health-harming behaviours in young adults: surveys in eight eastern European countries
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adverse childhood experiences and associations with health-harming behaviours in young adults: surveys in eight eastern European countries

BELLIS, Mark A ; HUGHES, Karen ; RALEVA, Marija ; TERZIC, Natasa ; LECKENBY, Nicola ; JONES, Lisa ; BABAN, Adriana ; KACHAEVA, Margarita ; PAVILAITIS, Robertas ; PUDULE, Iveta ; QIRJAKO, Gentiana ; ULUKOL, Betül

Bulletin of the World Health Organization, 2014-09, Vol.92 (9), p.641-655 [Periódico revisado por pares]

Genève: Organisation mondiale de la santé

Texto completo disponível

Citações Citado por
10
Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial
Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial

Smolen, Josef S, Prof ; Nash, Peter, MD ; Durez, Patrick, Prof ; Hall, Stephen, MD ; Ilivanova, Elena, MD ; Irazoque-Palazuelos, Fedra, MD ; Miranda, Pedro, MD ; Park, Min-Chan, MD ; Pavelka, Karel, Prof ; Pedersen, Ronald, MS ; Szumski, Annette, MS ; Hammond, Constance, BS ; Koenig, Andrew S, DO ; Vlahos, Bonnie, BSN

The Lancet (British edition), 2013-03, Vol.381 (9870), p.918-929 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (155)
  2. Revistas revisadas por pares (163)

Data de Publicação 

De até
Refinar
  1. Antes de1995  (15)
  2. 1995Até1999  (22)
  3. 2000Até2004  (39)
  4. 2005Até2010  (50)
  5. Após 2010  (43)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (162)
  2. Japonês  (23)
  3. Serbian  (3)
  4. Ucraniano  (2)
  5. Português  (1)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.